Oncology

NCT Precision Oncology Thesaurus Drugs – a Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer Medicine
Simon Kreutzfeldt, Alexander Knurr, Daniel Hübschmann, Peter Horak, Stefan Fröhling

medRxiv 2022.09.11.22279783; doi: https://doi.org/10.1101/2022.09.11.22279783

Add to Selected Citations
A comprehensive algorithmic dissection yields biomarker discovery and insights into the discrete stage-wise progression of colorectal cancer
Ashok Palaniappan, Arjun Sarathi

medRxiv 2022.08.16.22278877; doi: https://doi.org/10.1101/2022.08.16.22278877

Add to Selected Citations
Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment
Fulong Wang, Shixun Lu, Xin Zhou, Xiaotang Di, Rujia Wu, Gong Chen, Sun Tian

medRxiv 2022.06.20.22276657; doi: https://doi.org/10.1101/2022.06.20.22276657

Add to Selected Citations
Screening the use of DCA for the treatment of cancer in adult patients: a scoping review protocol
Cecilia Bianchi, Romina P Martinelli, Viviana R Rozados, O Graciela Scharovsky

medRxiv 2022.09.07.22279231; doi: https://doi.org/10.1101/2022.09.07.22279231

Add to Selected Citations
Fingolimod for treatment and or prevention of chemotherapy-induced peripheral neuropathy in humans?
Charles L. Loprinzi, Beth Harlos, Nathan Staff, David Zahrieh

medRxiv 2022.09.08.22279733; doi: https://doi.org/10.1101/2022.09.08.22279733

Add to Selected Citations
Changes in presentation, treatment, and survival of patients with hepatocellular carcinoma in Damietta, Egypt, 2007-2019: a retrospective monocentric cohort study
Kévin Jean, Ahmed Tawheed, Liem Binh Luong Nguye, Tarek Heikal, Usama Eldaly, Neven Elhadidy, Ahmed Elghaieb, Ahmed Aboudonia, Laura Tondeur, Amélie Dublineau, Arnaud Fontanet, Mohamed El-Kassas

medRxiv 2022.09.07.22279666; doi: https://doi.org/10.1101/2022.09.07.22279666

Add to Selected Citations
Healthy lifestyle, Agent Orange exposure, and inherited PCa risk: An analysis of the Million Veteran Program
Meghana S. Pagadala, Asona Lui, Julie Lynch, Roshan Karunamuni, Kyung Min Lee, Anna Plym, Brent S. Rose, Hannah Carter, Adam S. Kibel, Scott L. DuVall, J. Michael Gaziano, Matthew S. Panizzon, Richard L. Hauger, Tyler M. Seibert

medRxiv 2022.07.09.22277437; doi: https://doi.org/10.1101/2022.07.09.22277437

Add to Selected Citations
Detection of Somatic Copy Number Deletion of the CDKN2A Gene by Quantitative Multiplex PCR for Clinical Practice
Yuan Tian, Jing Zhou, Juanli Qiao, Zhaojun Liu, Liankun Gu, Baozhen Zhang, Youyong Lu, Rui Xing, Dajun Deng

medRxiv 2021.09.16.21263412; doi: https://doi.org/10.1101/2021.09.16.21263412

Add to Selected Citations
Relapse and non-relapse prediction using a sensitive circulating tumor DNA assay during colorectal cancer postoperative surveillance
Tomoko Sasaki, Takeshi Iwaya, Mizunori Yaegashi, Masashi Idogawa, Hayato Hiraki, Masakazu Abe, Yuka Koizumi, Noriyuki Sasaki, Akiko Yashima-Abo, Ryosuke Fujisawa, Fumitaka Endo, Shoichiro Tange, Tomomi Hirano, Koki Otsuka, Akira Sasaki, Mari Masuda, Masashi Fujita, Hidewaki Nakagawa, Fumiaki Takahashi, Yasushi Sasaki, Takashi Tokino, Satoshi S. Nishizuka

medRxiv 2022.09.03.22279571; doi: https://doi.org/10.1101/2022.09.03.22279571

Add to Selected Citations
A novel immunotherapy prognostic score for patients with pretreated advanced urinary tract carcinoma from the subgroup analysis of the SAUL study. The urInary TrAct CArcinoma score (ITACA)
Giuseppe Fornarini, Sara Elena Rebuzzi, Sebastiano Buti, Pasquale Rescigno, Axel Merseburger, Ugo de Giorgi, Umberto Basso, Marco Maruzzo, Patrizia Giannatempo, Marta Ponzano, Emilio Francesco Giunta, Fabio Catalano, Veronica Murianni, Alessandra Damassi, Malvina Cremante, Annalice Gandini, Silvia Puglisi, Miguel Angel Llaja Obispo, Alessio Signori, Giuseppe Luigi Banna

medRxiv 2022.08.30.22279352; doi: https://doi.org/10.1101/2022.08.30.22279352

Add to Selected Citations

Oncology

Pages